Skip to main content

Advertisement

SpringerLink
Log in

Cryosurgery for prostate cancer: New technology and indications

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Patients diagnosed with prostate cancer who elect to pursue active treatment of their disease must choose among the many available treatment alternatives. Several treatment options now exist for similar-stage disease (clinical T1-3N0M0), including radical prostatectomy, external beam radiation, prostate brachytherapy (PB), and cryosurgical ablation of the prostate (CSAP). This article reviews the current role of CSAP in the treatment of clinically localized prostate cancer. CSAP has a role in the primary treatment of men with high-risk, clinically localized prostate cancer (defined as PSA >10, Gleason score ≥ 7, or clinical stage ≥ cT2B). CSAP (occasionally followed by external beam radiotherapy) appears to offer improved rates of cancer control over other types of single or combination therapies for this high-risk prostate cancer, and it is associated with an acceptable side-effect profile. CSAP should also be the treatment of choice for men with recurrent local disease who have undergone external beam radiotherapy or PB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gibbons RP, Correa RJ, Brannen GE, et al.: Total prostatectomy for clinically localized prostatic cancer: long-term results. J Urol 1989, 141:564–566.

    PubMed  CAS  Google Scholar 

  2. Stamey TA, Ferrari MK, Schmid HP: The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients. J Urol 1993, 150:1856–1859.

    PubMed  CAS  Google Scholar 

  3. Gondor MJ, Soanes WA, Shulman S: Cryosurgical treatment of the prostate. Invest Urol 1966, 3:372–378.

    Google Scholar 

  4. Bonney WW, Fallon B, Gerber WL, et al.: Cryosurgery in prostate cancer: survival. Urology 1982, 14:37–42.

    Article  Google Scholar 

  5. Haab F, Boccon-Gibod L, Demass V, et al.: Perineal versus retropubic radical prostatectomy for T1, T2 prostate cancer. Brit J Urol 1994, 74:626–629.

    Article  PubMed  CAS  Google Scholar 

  6. Fowler FJ, Barry JJ, Lu-Yao G, et al.: Patient-reported complications and follow-up treatment after radical prostatectomy. Urology 1993, 42:622–629.

    Article  PubMed  Google Scholar 

  7. Shipley WU, Zietman AL, Hanks GE, et al.: Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor. J Urol 1994, 152:1799–1805.

    PubMed  CAS  Google Scholar 

  8. D’Amico AV, Coleman CN: Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. J Clin Oncol 1996, 14:304–315.

    PubMed  CAS  Google Scholar 

  9. Blasko JC, Wallner K, Grimm PD, et al.: Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma. J Urol 1995, 154:1096–1099.

    Article  PubMed  CAS  Google Scholar 

  10. Cohen JK, Rooker GM, Shuman BA, et al.: Cryosurgical Ablation: Management Alternative for Localized Prostate Cancer. In Textbook of Endourology. Edited by Smith AD. St. Louis: Quality Medical Publishing, Inc; 1996:1217–1233.

    Google Scholar 

  11. Chodak G: The role of watchful waiting in the management of localized prostate cancer. J Urol 1994, 152:1766–1768.

    PubMed  CAS  Google Scholar 

  12. Walsh PC, Partin AW, Epstein JI: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994, 152:1831–1836.

    PubMed  CAS  Google Scholar 

  13. Leibel SA, Zelefsky MJ, Kutcher GJ, et al.: Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase I dose-escalation study. J Urol 1994, 152:1792–1797.

    PubMed  CAS  Google Scholar 

  14. Cohen JK, Miller RJ Jr, Rooker GM, et al.: Four year PSA and biopsy results after cryosurgical ablation of the prostate (CSAP) for localized adenocarcinoma of the prostate [abstract]. J Urol 1997, 157:419A.

    Google Scholar 

  15. Benson MC, Kaplan SA, Olsson CA: Prostate cancer in men less than 45 years old: influence of stage, grade and therapy. J Urol 1987, 137:888.

    PubMed  CAS  Google Scholar 

  16. Bagshaw MA, Cox RS, Hancock SL: Control of prostate cancer with radiotherapy: long-term results. J Urol 1994, 152:1781–1785.

    PubMed  CAS  Google Scholar 

  17. Stock RG, Stone NN, Iannuzzi BA: Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1996, 35:267–272.

    Article  PubMed  CAS  Google Scholar 

  18. Milam DF, Franke JT: Prevention and treatment of incontinence after radical prostatectomy. Semin Urol Oncol 1995, 23:224–227.

    Google Scholar 

  19. Epstein JI: Incidence and significance of positive margins in radical prostatectomy margins. Urol Clin N Am 1996, 23:651–663.

    Article  CAS  Google Scholar 

  20. Miller RJ Jr, Cohen JK, Merlotti LA: Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of stage C adenocarcinoma of the prostate. Urology 1994, 44:170–174.

    Article  PubMed  Google Scholar 

  21. Polascik TJ, Pound CR, DeWeese TL, et al.: Comparison of radical prostatectomy and Iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. Urology 1998, 51:884–890.

    Article  PubMed  CAS  Google Scholar 

  22. Ramos CG, Carvahal GF, Smith DS, et al.: Retrospective comparison of radical retropubic prostatectomy and 125Iodine brachytherapy for localized prostate cancer. J Urol 1999, 161:1212–1215.

    Article  PubMed  CAS  Google Scholar 

  23. Pisters LL, von Eschenbach AC: Technique, results, and complications of “modern” prostate cryotherapy. AUA Update Series 1996, 15:297–304.

    Google Scholar 

  24. Rogers E, Ohori M, Kassabian VS, et al.: Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995, 153:104–110.

    Article  PubMed  CAS  Google Scholar 

  25. Pontes JE, Montie J, Klein E, et al.: Salvage surgery for radiation failure in prostate cancer. Cancer 1993, 71:976–980.

    Article  PubMed  CAS  Google Scholar 

  26. Badalament RA, Bahn DK, Kim J, et al.: Patient-reported complications after cryoablation therapy for prostate cancer. Urology 1999, 54:295–300. This is one of the only studies that reports complications after CSAP from a patient’s perspective. It is worth comparing with similar studies for radical prostatectomy, external beam radiotherapy, and PB.

    Article  PubMed  CAS  Google Scholar 

  27. Recastle JC, Sandison GA, Saliken JC, Donnelly BJ, McKinnon JG: Considerations during clinical operation of two commercially available cryomachines. J Surg Oncol 1999, 71:106–111.

    Article  Google Scholar 

  28. Chin JL, Downey DB, Mulligan M, Fenster A: Three-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in nonsurgical candidates: a feasibility study and report of early results. J Urol 1998, 159:910–914.

    Article  PubMed  CAS  Google Scholar 

  29. Vellet AD, Saliken J, Donellly B, et al.: Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications. Radiology 1997, 203:653–659.

    PubMed  CAS  Google Scholar 

  30. Tatsutani K, Rubinsky B, Onik G, Dahiya R: Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology 1996, 48:441–487.

    Article  PubMed  CAS  Google Scholar 

  31. Cozzi PJ, Lawson JA, Lynch WJ, Morris DL: Critical temperature for in vivo cryoablation of human prostate cancer in a xenograft model. Br J Urol 1996, 77:89–92.

    PubMed  CAS  Google Scholar 

  32. Pham L, Dahiya R, Rubinsky B: An in vivo study of antifreeze protein adjuvant cryosurgery. Cryobiology 1999.38:169–175,

    Article  PubMed  CAS  Google Scholar 

  33. Koushafer H, Rubinsky B: Effect of antifreeze proteins on frozen primary prostatic adenocarcinoma cells. Urology 1997, 49:421–425,

    Article  Google Scholar 

  34. Gould RS: Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery. J Urol 1999, 162:1653–1657. This article describes an interesting innovation in the performance of CSAP.

    Article  PubMed  CAS  Google Scholar 

  35. Cozzi PJ, Lynch WJ, Robson N, et al.:In vitro and in vivo assessment of urethral warming catheters for the transperineal cryoablation of prostatic carcinoma. Br J Urol 1996, 784:589–595.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Allegheny General Hospital, 1209 Allegheny Tower, 625 Stanwix Street, 15222, Pittsburgh, PA, USA

    Ronald M. Benoit MD, Jeffrey K. Cohen MD & Ralph J. Miller MD

Authors
  1. Ronald M. Benoit MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey K. Cohen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ralph J. Miller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benoit, R.M., Cohen, J.K. & Miller, R.J. Cryosurgery for prostate cancer: New technology and indications. Curr Urol Rep 1, 41–47 (2000). https://doi.org/10.1007/s11934-000-0034-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-000-0034-0

Keywords

Search

Navigation